Professional paper

Weekly and daily intake of alendronate: comparation of tolerance in osteoporosis treatment

Davorin Šakić ; Department for Physical Medicine and Rehabilitation, Clinical Hospital “Dubrava”, Zagreb, Croatia
Olga Badovinac ; Department for Physical Medicine and Rehabilitation, Clinical Hospital “Dubrava”, Zagreb, Croatia
Alboran Delija ; Department for Physical Medicine and Rehabilitation, Clinical Hospital “Dubrava”, Zagreb, Croatia
Vjekoslava Amerl Šakić ; Private general practice, Zagreb, Croatia

Abstract

In this study we analyzed, considering complains of patients, tolerance of taking alendronate 70 mg once a week in comparison with daily intake of alendronate 10 mg. Subjects were patients that were treated for osteoporosis at Department for physical medicine and rehabilitation in Clinical hospital Dubrava. The diagnosis of osteoporosis was established by DXA densitometry. Pains in oesophagus were the main reason for ceasing of use of alondronate. According to our research patients tolerate taking alendronate 70 weekly 4,22 times better than alendronate 10 daily.

Keywords

osteoporosis; alendromate; 10 mg daily dose; 70 mg weekly dose

Hrčak ID:

126027

URI

https://hrcak.srce.hr/126027

Publication date:

1.8.2004.

Article data in other languages: croatian

Visits: 741 *